Adaptimmune Therapeutics plc ADR logo

Adaptimmune Therapeutics plc ADR (ADAP)

Market Closed
21 Nov, 20:00
NASDAQ (CM) NASDAQ (CM)
$
0. 05
-0
-3%
$
12.53M Market Cap
- P/E Ratio
0% Div Yield
1,676,117 Volume
-0.44 Eps
$ 0.05
Previous Close
Day Range
0.04 0.06
Year Range
0.02 0.86
Want to track ADAP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
19 Nov 2025
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
12 Nov 2025
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
6 Nov 2025
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
5 Nov 2025
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
6 Aug 2025
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
14 May 2025
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
20 Mar 2025
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
14 Nov 2024
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
7 Aug 2024
-
Cons. EPS
0.24
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
31 May 2024
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
15 May 2024
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
6 Mar 2024
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
2 Nov 2023
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
10 Nov 2016
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
8 Aug 2016
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
12 May 2016
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
17 Mar 2016
-
Cons. EPS
-
EPS
Adaptimmune Therapeutics plc ADR logo
ADAP Adaptimmune Therapeutics plc ADR
13 Oct 2015
-
Cons. EPS
-
EPS

ADAP Earnings Reports FAQ

What is the earnings per share (EPS) for ADAP?

The current EPS is -0.44.

What is the company's earnings growth rate?

Adaptimmune Therapeutics plc ADR has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Adaptimmune Therapeutics plc ADR has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Adaptimmune Therapeutics plc ADR are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for ADAP at this time, as Adaptimmune Therapeutics plc ADR has no recent EPS data to calculate it.